Use of NK-1 receptor antagonists for the manufacture of a medicament for the treatment of abnormal anxiety behaviour in companion animals and method of screening a test compound to determine anxiolytic activity in dogs

The present invention relates to a method of treating abnormal anxiety behavior in companion animals comprising administering to a companion animal in need thereof a therapeutically effective amount of an NK-1 receptor antagonist.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HICKMAN MARY ANNE, KILROY CAROLYN ROSE, BRONK BRIAN SCOTT
Format:	Patent
Sprache:	eng ; slo
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a method of treating abnormal anxiety behavior in companion animals comprising administering to a companion animal in need thereof a therapeutically effective amount of an NK-1 receptor antagonist.